These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31654687)

  • 1. In vitro-in vivo correlation of parenteral PLGA microspheres: Effect of variable burst release.
    Andhariya JV; Jog R; Shen J; Choi S; Wang Y; Zou Y; Burgess DJ
    J Control Release; 2019 Nov; 314():25-37. PubMed ID: 31654687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Level A in vitro-in vivo correlations for peptide loaded PLGA microspheres.
    Andhariya JV; Jog R; Shen J; Choi S; Wang Y; Zou Y; Burgess DJ
    J Control Release; 2019 Aug; 308():1-13. PubMed ID: 31301338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro-in vivo correlation of parenteral risperidone polymeric microspheres.
    Shen J; Choi S; Qu W; Wang Y; Burgess DJ
    J Control Release; 2015 Nov; 218():2-12. PubMed ID: 26423236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro-in vivo correlation of PLGA microspheres: Effect of polymer source variation and temperature.
    Wan B; Bao Q; Burgess DJ
    J Control Release; 2022 Jul; 347():347-355. PubMed ID: 35569590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymer source affects in vitro-in vivo correlation of leuprolide acetate PLGA microspheres.
    Wan B; Bao Q; Wang R; Burgess DJ
    Int J Pharm; 2022 Sep; 625():122032. PubMed ID: 35878870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of in vitro-in vivo correlation of parenteral naltrexone loaded polymeric microspheres.
    Andhariya JV; Shen J; Choi S; Wang Y; Zou Y; Burgess DJ
    J Control Release; 2017 Jun; 255():27-35. PubMed ID: 28385676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Manufacturing Variables and Raw Materials on the Composition-Equivalent PLGA Microspheres for 1-Month Controlled Release of Leuprolide.
    Zhou J; Walker J; Ackermann R; Olsen K; Hong JKY; Wang Y; Schwendeman SP
    Mol Pharm; 2020 May; 17(5):1502-1515. PubMed ID: 32074448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S; Faraj J; DeLuca P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic evaluation of the initial burst release of leuprolide from spray-dried PLGA microspheres.
    Schutzman R; Shi NQ; Olsen KF; Ackermann R; Tang J; Liu YY; Hong JKY; Wang Y; Qin B; Schwendeman A; Schwendeman SP
    J Control Release; 2023 Sep; 361():297-313. PubMed ID: 37343723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse Engineering the 1-Month Lupron Depot®.
    Zhou J; Hirota K; Ackermann R; Walker J; Wang Y; Choi S; Schwendeman A; Schwendeman SP
    AAPS J; 2018 Oct; 20(6):105. PubMed ID: 30280294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of polymer source on in vitro drug release from PLGA microspheres.
    Wan B; Andhariya JV; Bao Q; Wang Y; Zou Y; Burgess DJ
    Int J Pharm; 2021 Sep; 607():120907. PubMed ID: 34332059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of PLGA molecular weight differences on risperidone release from microspheres.
    Kohno M; Andhariya JV; Wan B; Bao Q; Rothstein S; Hezel M; Wang Y; Burgess DJ
    Int J Pharm; 2020 May; 582():119339. PubMed ID: 32305366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of minor manufacturing changes on stability of compositionally equivalent PLGA microspheres.
    Andhariya JV; Shen J; Wang Y; Choi S; Burgess DJ
    Int J Pharm; 2019 Jul; 566():532-540. PubMed ID: 31181309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of polymer source variation on the properties and performance of risperidone microspheres.
    Wan B; Bao Q; Zou Y; Wang Y; Burgess DJ
    Int J Pharm; 2021 Dec; 610():121265. PubMed ID: 34748813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of PLGA molecular weight distribution on leuprolide release from microspheres.
    Ochi M; Wan B; Bao Q; Burgess DJ
    Int J Pharm; 2021 Apr; 599():120450. PubMed ID: 33675924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preparation and evaluation of risperidone-loaded microsphere/sucrose acetate isobutyrate in situ forming complex depot with double diffusion barriers].
    Lin X; Tang X; Xu YH; Zhang Y; Zhang Y; He HB
    Yao Xue Xue Bao; 2015 Jun; 50(6):775-82. PubMed ID: 26521452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Uniform Ultra-Small Microsphere/SAIB Hybrid Depot with Low Burst Release for Long-Term Continuous Drug Release.
    Lin X; Xu Y; Tang X; Zhang Y; Chen J; Zhang Y; He H; Yang Z
    Pharm Res; 2015 Nov; 32(11):3708-21. PubMed ID: 26077999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tracking the effect of microspheres size on the drug release from a microsphere/sucrose acetate isobutyrate (SAIB) hybrid depot in vitro and in vivo.
    Lin X; Wang J; Xu Y; Tang X; Chen J; Zhang Y; Zhang Y; Yang Z
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1455-65. PubMed ID: 26790718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of drying processes on the structures, morphology and
    Wu Z; Zhao M; Zhang W; Yang Z; Xu S; Shang Q
    J Microencapsul; 2019 Jan; 36(1):21-31. PubMed ID: 30757946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Goserelin Acetate Loaded Poloxamer Hydrogel in PLGA Microspheres: Core-Shell Di-Depot Intramuscular Sustained Release Delivery System.
    Qi P; Bu R; Zhang H; Yin J; Chen J; Zhang A; Gou J; Yin T; Zhang Y; He H; Wang P; Tang X; Wang Y
    Mol Pharm; 2019 Aug; 16(8):3502-3513. PubMed ID: 31251642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.